Oaktree Specialty Lending Co. (NASDAQ:OCSL – Get Free Report) declared a quarterly dividend on Tuesday, November 19th,Wall Street Journal reports. Investors of record on Monday, December 16th will be given a dividend of 0.55 per share by the credit services provider on Tuesday, December 31st. This represents a $2.20 dividend on an annualized basis and a yield of 13.72%. The ex-dividend date of this dividend is Monday, December 16th.
Oaktree Specialty Lending has a dividend payout ratio of 95.2% indicating that its dividend is currently covered by earnings, but may not be in the future if the company’s earnings fall. Equities research analysts expect Oaktree Specialty Lending to earn $1.98 per share next year, which means the company may not be able to cover its $2.20 annual dividend with an expected future payout ratio of 111.1%.
Oaktree Specialty Lending Trading Down 1.2 %
OCSL opened at $16.04 on Friday. The business’s 50 day moving average price is $16.18 and its 200 day moving average price is $17.14. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.19 and a current ratio of 0.19. The stock has a market capitalization of $1.32 billion, a PE ratio of 22.28 and a beta of 1.07. Oaktree Specialty Lending has a one year low of $15.40 and a one year high of $21.64.
Wall Street Analyst Weigh In
Get Our Latest Research Report on Oaktree Specialty Lending
Oaktree Specialty Lending Company Profile
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies.
Further Reading
- Five stocks we like better than Oaktree Specialty Lending
- What is the Dogs of the Dow Strategy? Overview and Examples
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Top Biotech Stocks: Exploring Innovation Opportunities
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Oaktree Specialty Lending Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Specialty Lending and related companies with MarketBeat.com's FREE daily email newsletter.